Spots Global Cancer Trial Database for Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

Official Title: Understanding Barriers Associated With Timely Chemotherapy Administration Among Breast Cancer Patients

Study ID: NCT04087057

Conditions

Invasive Breast Carcinoma

Interventions

Interview

Medical Chart Review

Questionnaire

Study Description

Brief Summary: This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients with breast cancer.

Detailed Description: PRIMARY OBJECTIVES: I. To comprehensively and qualitatively assess and identify the determinants of time to chemotherapy (TTC) delays in a vulnerable population using qualitative methods. Ia. To describe the health literacy/numeracy, social support and level of trust in physicians of the study participants. (Exploratory) OUTLINE: Patients complete questionnaires and participate in an interview to answer questions about the information patients received before starting the chemotherapy, any medical problems after the surgery that could have been related to the start of the chemotherapy, how the chemotherapy affected patients' life, and anything else patients may remember between the time when the breast surgery ended and the first dose of chemotherapy started. Patients' medical records are also reviewed.